The menopause AI answer layer did not exist five years ago. Between 2020 and 2025, the category was built — primarily by venture-backed telehealth clinics, not by academic medicine or OBGYN professional associations.
The result: Midi Health, Alloy Women's Health, and one OB-GYN with a book dominate the menopause AI answer layer. The American College of Obstetricians and Gynecologists appears at Tier 2. Academic medical centers appear at Tier 3. Pfizer and AbbVie — whose products are the most prescribed — appear rarely in AI answers about menopause care.
This is the fastest example in the Citation Share Index of how a new category's AI answer layer gets built from scratch — and how the entities that build it first own it for years. The same pattern is documented across mental health in The Mental Health Citation Gap: Why BetterHelp Beats the APA.
How Midi Health and Alloy Built the Layer
Both companies launched between 2020 and 2022 into a category where the incumbent voices — academic medicine, professional associations, pharma — were either absent from consumer media or communicating in the clinical register that consumer audiences didn't search for and AI engines didn't weight for consumer queries.
The strategic insight: the AI answer layer for menopause care would be built from consumer-facing content, not from clinical guidelines. The buyer asking "what are the best treatments for menopause symptoms" is not asking for ACOG clinical practice guidelines. They are asking for something in the register of a well-cited clinic explainer. Midi and Alloy produced content in that register, at scale, for the queries buyers actually used — named physicians writing in a consumer register, with FAQ schema, published across channels that earned backlinks from major women's health and lifestyle publications.
By the time AI engines were weighting content archives for menopause queries, Midi and Alloy had built the archives the engines found. ACOG had not. Neither had the pharmaceutical companies that make the most-prescribed treatments. For why the structural advantage of category-native content is durable, see The Hodinkee Lesson: LLM Citation Authority Is Sticky.
The Named OB-GYN Advantage
The third Tier 1 position in menopause AI citation is held by a named individual OB-GYN with a published book, a substantial social media presence, and bylines in major publications. This individual is not associated with a major clinic or health system. The citation advantage comes entirely from the named-individual content archive: verifiable credentials, consistent byline history, a book cited by other sources. This is the named-practitioner pattern documented in The 5 Sources That Appear in Every AI Answer — the individual builds the archive, the archive builds the citation, the citation precedes the institution in the AI answer.
What This Means for Pharma and Traditional Healthcare
The pharmaceutical companies and academic medical institutions that dominate menopause care by prescription volume have a serious AI visibility problem they didn't create and haven't addressed. Correcting this requires exactly what Midi and Alloy did: named physicians, consumer register, FAQ structure, channel distribution that earns authoritative inbound links. It takes years to build an archive that can compete with one that has a 5-year head start. For the broader regulatory floor that traditional healthcare does own in AI answers, see The Regulatory Floor: Why .gov Sources Anchor Every AI Answer.
Related Analysis
- The Mental Health Citation Gap: Why BetterHelp Beats the APA — the same pattern in mental health
- Wellness PR & AI Visibility: The Complete Guide
- The Hodinkee Lesson: LLM Citation Authority Is Sticky
- Why Category-Native Publications Beat Legacy Media in AI Answers
- The 5 Sources That Appear in Every AI Answer
- The Citation Share Index
- Everything-PR Research Index
